Storys zum Thema Factor H

Folgen
Keine Story zum Thema Factor H mehr verpassen.
Filtern
  • 12.10.2021 – 10:30

    eleva GmbH

    Eleva Enters Clinical Development of Difficult-To-Express High-Potential Proteins

    Freiburg (ots) - Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candidates, such as immune-regulating factor H, as well as in collaboration with pharmaceutical partners. Its moss-based platform is ideally suited to produce difficult-to-express but therapeutically promising drug candidates. Its recently expanded production ...

  • 03.06.2020 – 10:00

    eleva GmbH

    Eleva's drug candidate to be examined for use in Covid-19 treatment

    Freiburg (ots) - Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of Covid-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the course of Covid-19. Eleva has developed factor H previously for a different indication and taken it through ...